CLINICAL_TRIALS
trial_result
· 2024-07-05
Clinical Trial Update: Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer [Phase 1]
Summary
A Phase 1 study of AMG 160 in non-small cell lung cancer was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Non-small Cell Lung Cancer, NSCLC | Phase 1 | Status: TERMINATED | Results posted: 2024-07-05